IPO registrations (S-1, F-1) · Registrants
ROSETTA INPHARMATICS INC
- SEC CIK
- 1081935 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-03-17, last 2000-08-02; 1 initial registration, 7 amendments
- Outcome
- Final prospectus filed 2000-08-04
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Business address
- 12040 115TH AVE NE, SUITE 210, Kirkland, WA 98034
- EIN
- 91-1770023
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2000-08-02)
- Final price
- $14.00 per share, above the range (424B4 filed 2000-08-04, an initial public offering)
- Shares sold
- 7,200,000
- Gross proceeds
- $100,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol RSTA
- Lead underwriters
- Lehman Brothers (3,100,000 shares); Lazard (1,550,000 shares); Prudential Securities (1,550,000 shares)
- Syndicate
- Fidelity Capital Markets; J.P. Morgan (75,000); CIBC World Markets (75,000); A.G. Edwards (75,000); Robertson Stephens (75,000); ING Barings LLC (75,000); Cowen (75,000); William Blair (40,000); Gerard Klauer Mattison & Co., Inc (40,000); Gruntal & Co., L.L.C (40,000); Oscar Gruss & Son, Incorporated (40,000); Edward D. Jones & Co., L.P (40,000); Pennsylvania Merchant Group (40,000); Raymond James (40,000); Ragen MacKenzie Incorporated (40,000); Wm Smith Securities, Incorporated (40,000); Wachovia (40,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: ROSETTA INPHARMATICS, LLC Fuzzy (name and state)
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-03-17 | S-1 | S-1 (registration) | ROSETTA INPHARMATICS INC | 0000912057-00-012266 ↗ |
| 2000-04-05 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-016344 ↗ |
| 2000-05-09 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-022643 ↗ |
| 2000-06-14 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-028492 ↗ |
| 2000-06-21 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-029224 ↗ |
| 2000-07-11 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-031419 ↗ |
| 2000-07-26 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-033280 ↗ |
| 2000-08-02 | S-1/A | S-1/A (amendment) | ROSETTA INPHARMATICS INC | 0000912057-00-034317 ↗ |
| 2000-08-03 | S-1MEF | S-1MEF (added securities) | ROSETTA INPHARMATICS INC | 0000912057-00-034391 ↗ |
| 2000-08-04 | 424B4 | 424B4 (final prospectus) | ROSETTA INPHARMATICS INC | 0000912057-00-034617 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-08-02 | S-1/A | registration statement | $10.00–$12.00 | $11.00 | 7,000,000 | $77,000,000 | Nasdaq RSTA | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2000-08-04 | 424B4 | final prospectus | $14.00 | 7,200,000 | $100,800,000 | Nasdaq RSTA | 20 | primary document; price sentence, shares headline, proceeds table, underwriting table 19, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | ROSETTA INPHARMATICS, LLC | WA | Federal spending (USAspending) | name and state |
| Patent assignee | Rosetta Inpharmatics LLC | WA | Patents (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, WA first:
- Cascadian Therapeutics, Inc. WA
- Absci Corp WA
- WEED, INC. AZ
- GLYCOTEX, INC. C3
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- SIGNAL PHARMACEUTICALS INC CA
- DELTAGEN INC CA
- MAXYGEN INC CA
- KOSAN BIOSCIENCES INC CA
In other datasets, the same topic (Medical research) in WA:
- Form D issuer: AbSci Corp (Form D private offerings)
- Nonprofit: ACCESS ABILITIES UNLIMITED (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research